Dr. Durdin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1904 Pine St
Ste 3A
Abilene, TX 79601Phone+1 325-670-6180Fax+1 833-437-1278
Summary
- Urologic Oncologist serving the cancer needs of West Texas
Education & Training
- Memorial Sloan Kettering Cancer CenterFellowship, Urologic Surgical Oncology, 2020 - 2022
- Texas A&M College of Medicine-Scott and White Medical Center (Temple)Residency, Urology, 2015 - 2020
- Texas Tech University Health Sciences Center School of MedicineClass of 2015
- Texas A&MB.S., Biomedical Science, 2007 - 2011
Certifications & Licensure
- NY State Medical License 2019 - 2025
- TX State Medical License 2018 - 2025
Publications & Presentations
PubMed
- 1 citationsDevelopment and Validation of a Multivariable Nomogram Predictive of Post-Nephroureterectomy Renal Function.Patrick J Hensley, Craig Labbate, Andrew Zganjar, Jeffrey Howard, Heather Huelster
European Urology Oncology. 2024-12-01 - 30 citationsNeoadjuvant Atezolizumab With Gemcitabine and Cisplatin in Patients With Muscle-Invasive Bladder Cancer: A Multicenter, Single-Arm, Phase II Trial.Samuel A Funt, Michael Lattanzi, Karissa Whiting, Hikmat Al-Ahmadie, Colleen Quinlan
Journal of Clinical Oncology. 2022-04-20 - 5 citationsCan an Imaging-guided Pathway Replace the Current Paradigm for Muscle-invasive Bladder Cancer?Trey Durdin, Alvin C. Goh, Eugene J. Pietzak
European Urology. 2021-04-08
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: